Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955181630> ?p ?o ?g. }
- W2955181630 abstract "GDF15 (growth/differentiation factor 15), also known as MIC-1 (Macrophage inhibitory cytokine 1), is a divergent member of the TGFβ superfamily of cytokines and is highly expressed in prostate tumors, but its role in prostate carcinogenesis and utility as a prognostic biomarker is unclear. We studied 91 prostate cancer cases that underwent surgery as their primary treatment and were then subsequently followed for biochemical recurrence (BCR). These cases also had a benign prostate biopsy at least one year before their prostate cancer diagnosis. In both the benign biopsy and tumor specimens, we quantified the intensity of GDF15 expression and characterized the presence of tumor associated macrophages by measuring the density of CD68-positive stained cells, and the M2 macrophage marker CD204 by immunohistochemical analysis. Marker expression was measured in prostate a) benign biopsy (BS), b) tumor-adjacent benign (BGS) and c) tumor tissue (MGS) using an automated multi-image processing macro developed in the ImageJ software. A Cox proportional hazards model was used to test the association of time to BCR of the low expression group compared with medium or high biomarker expression. The risk of BCR differed with the extent of GDF15 expression in the prostatic epithelial tissue of benign and tumor regions of the prostate. For instance, in BGS, high expression of GDF15 was associated with increased risk of BCR (hazard ratio (HR)=2.58, p=0.07). After controlling for PSA at diagnosis, Gleason grade and pathologic stage, high expression of GDF15 in BGS had a stronger association with BCR (HR=3.30, p=0.04). The risk of BCR increased with increasing level of infiltration of CD204/CD68 positive macrophages in BGS (HR=4.19, p=0.02) and MGS (HR=4.16, p=0.01) even after controlling for PSA at diagnosis, Gleason grade and pathologic stage. The combined expression levels of GDF15 and CD204/CD68 showed that prostate cancer cases with small GDF15 expression changes between BGS and MGS and high CD204/CD68 expression in BGS were at 3-fold higher risk of BCR (HR=3.67, p=0.05). In summary, expression levels of GDF15 and CD204 M2 macrophages in different regions of the prostate can change as the disease progresses from benign to a tumorigenic state and serve as markers for aggressive disease. Further evaluation of these dynamic differences in the prostate immune cellular profile in the pre-malignant and malignant state may offer additional insight into inflammatory-mediated prostate carcinogenesis. Citation Format: Sudha M. Sadasivan, Yalei Chen, Nilesh Gupta, Sean Williamson, Dhananjay Chitale, Xiaoxia Han, Kevin Bobbitt, Andrew Rundle, Deliang Tang, Benjamin A. Rybicki. Changes in GDF15 (growth/differentiation factor 15) expression and M2 macrophages during prostate carcinogenesis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2337." @default.
- W2955181630 created "2019-07-12" @default.
- W2955181630 creator A5000395977 @default.
- W2955181630 creator A5002668535 @default.
- W2955181630 creator A5024718359 @default.
- W2955181630 creator A5027709185 @default.
- W2955181630 creator A5035686687 @default.
- W2955181630 creator A5042292630 @default.
- W2955181630 creator A5048067406 @default.
- W2955181630 creator A5074861972 @default.
- W2955181630 creator A5085688534 @default.
- W2955181630 creator A5087780392 @default.
- W2955181630 date "2019-07-01" @default.
- W2955181630 modified "2023-09-28" @default.
- W2955181630 title "Abstract 2337: Changes in GDF15 (growth/differentiation factor 15) expression and M2 macrophages during prostate carcinogenesis" @default.
- W2955181630 doi "https://doi.org/10.1158/1538-7445.sabcs18-2337" @default.
- W2955181630 hasPublicationYear "2019" @default.
- W2955181630 type Work @default.
- W2955181630 sameAs 2955181630 @default.
- W2955181630 citedByCount "0" @default.
- W2955181630 crossrefType "proceedings-article" @default.
- W2955181630 hasAuthorship W2955181630A5000395977 @default.
- W2955181630 hasAuthorship W2955181630A5002668535 @default.
- W2955181630 hasAuthorship W2955181630A5024718359 @default.
- W2955181630 hasAuthorship W2955181630A5027709185 @default.
- W2955181630 hasAuthorship W2955181630A5035686687 @default.
- W2955181630 hasAuthorship W2955181630A5042292630 @default.
- W2955181630 hasAuthorship W2955181630A5048067406 @default.
- W2955181630 hasAuthorship W2955181630A5074861972 @default.
- W2955181630 hasAuthorship W2955181630A5085688534 @default.
- W2955181630 hasAuthorship W2955181630A5087780392 @default.
- W2955181630 hasConcept C121608353 @default.
- W2955181630 hasConcept C126322002 @default.
- W2955181630 hasConcept C136935669 @default.
- W2955181630 hasConcept C142724271 @default.
- W2955181630 hasConcept C143998085 @default.
- W2955181630 hasConcept C170493617 @default.
- W2955181630 hasConcept C204232928 @default.
- W2955181630 hasConcept C2775934546 @default.
- W2955181630 hasConcept C2776235491 @default.
- W2955181630 hasConcept C2776438761 @default.
- W2955181630 hasConcept C2776460901 @default.
- W2955181630 hasConcept C2777562237 @default.
- W2955181630 hasConcept C2779723316 @default.
- W2955181630 hasConcept C2780192828 @default.
- W2955181630 hasConcept C2781197716 @default.
- W2955181630 hasConcept C2781217009 @default.
- W2955181630 hasConcept C43907098 @default.
- W2955181630 hasConcept C502942594 @default.
- W2955181630 hasConcept C55493867 @default.
- W2955181630 hasConcept C555283112 @default.
- W2955181630 hasConcept C71924100 @default.
- W2955181630 hasConcept C86803240 @default.
- W2955181630 hasConcept C87874733 @default.
- W2955181630 hasConceptScore W2955181630C121608353 @default.
- W2955181630 hasConceptScore W2955181630C126322002 @default.
- W2955181630 hasConceptScore W2955181630C136935669 @default.
- W2955181630 hasConceptScore W2955181630C142724271 @default.
- W2955181630 hasConceptScore W2955181630C143998085 @default.
- W2955181630 hasConceptScore W2955181630C170493617 @default.
- W2955181630 hasConceptScore W2955181630C204232928 @default.
- W2955181630 hasConceptScore W2955181630C2775934546 @default.
- W2955181630 hasConceptScore W2955181630C2776235491 @default.
- W2955181630 hasConceptScore W2955181630C2776438761 @default.
- W2955181630 hasConceptScore W2955181630C2776460901 @default.
- W2955181630 hasConceptScore W2955181630C2777562237 @default.
- W2955181630 hasConceptScore W2955181630C2779723316 @default.
- W2955181630 hasConceptScore W2955181630C2780192828 @default.
- W2955181630 hasConceptScore W2955181630C2781197716 @default.
- W2955181630 hasConceptScore W2955181630C2781217009 @default.
- W2955181630 hasConceptScore W2955181630C43907098 @default.
- W2955181630 hasConceptScore W2955181630C502942594 @default.
- W2955181630 hasConceptScore W2955181630C55493867 @default.
- W2955181630 hasConceptScore W2955181630C555283112 @default.
- W2955181630 hasConceptScore W2955181630C71924100 @default.
- W2955181630 hasConceptScore W2955181630C86803240 @default.
- W2955181630 hasConceptScore W2955181630C87874733 @default.
- W2955181630 hasLocation W29551816301 @default.
- W2955181630 hasOpenAccess W2955181630 @default.
- W2955181630 hasPrimaryLocation W29551816301 @default.
- W2955181630 hasRelatedWork W1505808453 @default.
- W2955181630 hasRelatedWork W1945293306 @default.
- W2955181630 hasRelatedWork W2011946110 @default.
- W2955181630 hasRelatedWork W2053348763 @default.
- W2955181630 hasRelatedWork W2129964802 @default.
- W2955181630 hasRelatedWork W2136915808 @default.
- W2955181630 hasRelatedWork W2384016218 @default.
- W2955181630 hasRelatedWork W2408801655 @default.
- W2955181630 hasRelatedWork W2887620342 @default.
- W2955181630 hasRelatedWork W2929161590 @default.
- W2955181630 hasRelatedWork W2990809684 @default.
- W2955181630 hasRelatedWork W3021637971 @default.
- W2955181630 hasRelatedWork W3028272213 @default.
- W2955181630 hasRelatedWork W3030492463 @default.
- W2955181630 hasRelatedWork W3038226937 @default.
- W2955181630 hasRelatedWork W3083325828 @default.
- W2955181630 hasRelatedWork W3131946619 @default.
- W2955181630 hasRelatedWork W3134549956 @default.
- W2955181630 hasRelatedWork W3180145123 @default.
- W2955181630 hasRelatedWork W2546609602 @default.